JAMP Pharma Group signs a landmark partnership agreement

JAMP Pharma Group signs a landmark partnership agreement

Canadian pharmaceutical company JAMP Pharma Group has signed an exclusive agreement with global speciality biopharmaceutical company Alvotech for the Canadian commercial rights to five biosimilars. The current market value of the branded sales for these five biosimilars is estimated to be exceeding $2 billion annually in Canada.  Read the Press Release

 

Member Forum

September 14, 2021

MORE INFO

Boot Camp

November 23 - 24, 2021

MORE INFO

Executive Conference

January 10 - 11, 2022
Montreal Airport Marriott In-Terminal Hotel
Dorval, QC

MORE INFO

Annual Conference

May 1 - 4, 2022
Sparkling Hill Resort
Vernon, British Columbia

MORE INFO